A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

Clinical trial NCT07282353 · RECRUITING

Trial details

NCT number: NCT07282353
Sponsor: Cascade Pharmaceuticals, Inc
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Biliary Cholangitis

Start date: 2025-12-01
Primary completion: 2027-12-09
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.